STOCK TITAN

[Form 4] La Rosa Holding Corp. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

On 15 Jul 2025, XBP Americas, LLC, a wholly-owned subsidiary of XBP Europe Holdings, Inc. (Nasdaq: XBP / XBPEW), closed the acquisition of 100% of Exela Technologies BPA, LLC and its subsidiaries (the “BPA Group”) from Exela Technologies, Inc. under the Membership Interest Purchase Agreement signed 3 Jul 2025.

The purchase price was only $1.00 because the BPA Group is operating under Chapter 11 bankruptcy (case “In re DocuData Solutions, L.C.”) and carries substantial encumbrances. The deal is classified as a related-party transaction as both buyer and seller share common ownership.

The transaction contains conditions subsequent: if the bankruptcy reorganization plan is not effective or other conditions are unmet by 7 Aug 2025, XBP can rescind the purchase. The filing provides no pro-forma financials, synergies or earnings guidance.

Key implications: XBP gains potential upside from a distressed asset at minimal cash cost but assumes restructuring risk and faces governance scrutiny due to the affiliated nature of the deal.

Il 15 luglio 2025, XBP Americas, LLC, una controllata interamente posseduta da XBP Europe Holdings, Inc. (Nasdaq: XBP / XBPEW), ha completato l'acquisizione del 100% di Exela Technologies BPA, LLC e delle sue controllate (il “Gruppo BPA”) da Exela Technologies, Inc. in base al Contratto di Acquisto delle Quote sottoscritto il 3 luglio 2025.

Il prezzo di acquisto è stato di soli $1,00 poiché il Gruppo BPA opera sotto il Capitolo 11 di fallimento (caso “In re DocuData Solutions, L.C.”) e presenta rilevanti vincoli finanziari. L’operazione è classificata come una transazione tra parti correlate dato che acquirente e venditore condividono la stessa proprietà.

La transazione prevede condizioni successive: se il piano di riorganizzazione fallimentare non sarà efficace o altre condizioni non saranno soddisfatte entro il 7 agosto 2025, XBP potrà annullare l’acquisto. La documentazione non include dati finanziari pro-forma, sinergie o previsioni di utili.

Implicazioni principali: XBP acquisisce un asset potenzialmente vantaggioso a costo di cassa minimo, ma assume il rischio di ristrutturazione e si espone a controlli di governance a causa della natura affiliata dell’operazione.

El 15 de julio de 2025, XBP Americas, LLC, una subsidiaria de propiedad total de XBP Europe Holdings, Inc. (Nasdaq: XBP / XBPEW), cerró la adquisición del 100% de Exela Technologies BPA, LLC y sus subsidiarias (el “Grupo BPA”) de Exela Technologies, Inc. bajo el Acuerdo de Compra de Participaciones firmado el 3 de julio de 2025.

El precio de compra fue solo $1.00 porque el Grupo BPA opera bajo el Capítulo 11 de bancarrota (caso “In re DocuData Solutions, L.C.”) y tiene cargas financieras significativas. La operación se clasifica como una transacción entre partes relacionadas ya que comprador y vendedor comparten propiedad común.

La transacción incluye condiciones posteriores: si el plan de reorganización de bancarrota no es efectivo o no se cumplen otras condiciones antes del 7 de agosto de 2025, XBP puede rescindir la compra. La presentación no proporciona estados financieros proforma, sinergias ni guía de ganancias.

Implicaciones clave: XBP obtiene potencial beneficio de un activo en dificultades con un costo de efectivo mínimo, pero asume riesgo de reestructuración y enfrenta escrutinio de gobernanza debido a la naturaleza afiliada del acuerdo.

2025년 7월 15일, XBP Americas, LLC는 XBP Europe Holdings, Inc. (나스닥: XBP / XBPEW)의 전액 출자 자회사로서, 2025년 7월 3일 서명된 회원 지분 매매 계약에 따라 Exela Technologies, Inc.로부터 Exela Technologies BPA, LLC 및 그 자회사들(“BPA 그룹”)의 100% 지분 인수를 완료했습니다.

매매 가격은 단 $1.00에 불과했는데, 이는 BPA 그룹이 챕터 11 파산 절차(“In re DocuData Solutions, L.C.” 사건) 하에 운영 중이며 상당한 담보권이 설정되어 있기 때문입니다. 이 거래는 매수자와 매도자가 공동 소유권을 공유하는 특수 관계자 거래로 분류됩니다.

거래에는 후속 조건이 포함되어 있습니다: 파산 재조정 계획이 효력을 발휘하지 않거나 2025년 8월 7일까지 기타 조건이 충족되지 않을 경우, XBP는 매매를 철회할 수 있습니다. 제출 자료에는 예상 재무제표, 시너지 효과 또는 수익 가이던스가 포함되어 있지 않습니다.

주요 시사점: XBP는 최소 현금 비용으로 부실 자산에서 잠재적 이익을 얻는 반면, 구조조정 위험을 부담하고 거래의 계열사 성격으로 인해 거버넌스 감시를 받게 됩니다.

Le 15 juillet 2025, XBP Americas, LLC, une filiale en propriété exclusive de XBP Europe Holdings, Inc. (Nasdaq : XBP / XBPEW), a finalisé l'acquisition de 100 % d’Exela Technologies BPA, LLC et de ses filiales (le « Groupe BPA ») auprès d’Exela Technologies, Inc., conformément à l’accord d’achat de parts signé le 3 juillet 2025.

Le prix d’achat s’est élevé à seulement 1,00 $ car le Groupe BPA est en procédure de faillite sous le Chapitre 11 (dossier « In re DocuData Solutions, L.C. ») et supporte d’importantes charges financières. L’opération est qualifiée de transaction entre parties liées puisque l’acheteur et le vendeur ont une propriété commune.

La transaction comporte des conditions suspensives : si le plan de réorganisation de la faillite n’est pas effectif ou si d’autres conditions ne sont pas remplies avant le 7 août 2025, XBP peut annuler l’achat. Le dossier ne fournit pas d’états financiers pro forma, de synergies ou de prévisions de bénéfices.

Principales implications : XBP bénéficie d’un potentiel de valorisation d’un actif en difficulté à un coût en liquidités minimal, mais assume le risque de restructuration et fait face à un contrôle de gouvernance en raison de la nature affiliée de la transaction.

Am 15. Juli 2025 hat XBP Americas, LLC, eine hundertprozentige Tochtergesellschaft von XBP Europe Holdings, Inc. (Nasdaq: XBP / XBPEW), die Übernahme von 100 % von Exela Technologies BPA, LLC und deren Tochtergesellschaften (die „BPA-Gruppe“) von Exela Technologies, Inc. unter dem am 3. Juli 2025 unterzeichneten Mitgliedschaftsanteilkaufvertrag abgeschlossen.

Der Kaufpreis betrug lediglich 1,00 $, da die BPA-Gruppe sich im Chapter-11-Insolvenzverfahren befindet (Fall „In re DocuData Solutions, L.C.“) und erhebliche Belastungen aufweist. Der Deal wird als Geschäft mit verbundenen Parteien eingestuft, da Käufer und Verkäufer gemeinsame Eigentümer sind.

Die Transaktion enthält aufschiebende Bedingungen: Sollte der Insolvenzplan nicht wirksam werden oder andere Bedingungen bis zum 7. August 2025 nicht erfüllt sein, kann XBP den Kauf rückgängig machen. Es werden keine pro-forma-Finanzzahlen, Synergien oder Gewinnprognosen vorgelegt.

Wesentliche Auswirkungen: XBP erhält potenziellen Mehrwert aus einem notleidenden Vermögenswert zu minimalen Barzahlungskosten, übernimmt aber Restrukturierungsrisiken und steht aufgrund der verbundenen Natur des Geschäfts unter Governance-Prüfung.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Nominal $1 purchase of bankrupt BPA Group adds scope but embeds restructuring risk; related-party nature heightens governance scrutiny—impact modest but watch conditions.

The consideration signals that liabilities likely outweigh assets, so value depends on a successful Chapter 11 reorganization. Because rescission is allowed until 7 Aug 2025, the closing is provisional, limiting immediate balance-sheet impact. Strategic upside exists if BPA’s client relationships survive bankruptcy, yet integration costs and potential claims could offset gains. Investors should track court milestones and any forthcoming pro-forma disclosures before revising forecasts.

TL;DR: Related-party $1 deal raises conflict-of-interest and liability concerns; investors need transparency on liabilities and condition fulfilment before Aug 7.

Common ownership complicates independence of the valuation and approval process. Absence of fairness opinion or independent director review is not addressed, elevating minority-shareholder risk. The short window for rescission suggests unfinished due diligence. Governance best practice would require detailed disclosure of assumed obligations and board oversight; the filing is silent on these areas, skewing risk to the downside until additional information is provided.

Il 15 luglio 2025, XBP Americas, LLC, una controllata interamente posseduta da XBP Europe Holdings, Inc. (Nasdaq: XBP / XBPEW), ha completato l'acquisizione del 100% di Exela Technologies BPA, LLC e delle sue controllate (il “Gruppo BPA”) da Exela Technologies, Inc. in base al Contratto di Acquisto delle Quote sottoscritto il 3 luglio 2025.

Il prezzo di acquisto è stato di soli $1,00 poiché il Gruppo BPA opera sotto il Capitolo 11 di fallimento (caso “In re DocuData Solutions, L.C.”) e presenta rilevanti vincoli finanziari. L’operazione è classificata come una transazione tra parti correlate dato che acquirente e venditore condividono la stessa proprietà.

La transazione prevede condizioni successive: se il piano di riorganizzazione fallimentare non sarà efficace o altre condizioni non saranno soddisfatte entro il 7 agosto 2025, XBP potrà annullare l’acquisto. La documentazione non include dati finanziari pro-forma, sinergie o previsioni di utili.

Implicazioni principali: XBP acquisisce un asset potenzialmente vantaggioso a costo di cassa minimo, ma assume il rischio di ristrutturazione e si espone a controlli di governance a causa della natura affiliata dell’operazione.

El 15 de julio de 2025, XBP Americas, LLC, una subsidiaria de propiedad total de XBP Europe Holdings, Inc. (Nasdaq: XBP / XBPEW), cerró la adquisición del 100% de Exela Technologies BPA, LLC y sus subsidiarias (el “Grupo BPA”) de Exela Technologies, Inc. bajo el Acuerdo de Compra de Participaciones firmado el 3 de julio de 2025.

El precio de compra fue solo $1.00 porque el Grupo BPA opera bajo el Capítulo 11 de bancarrota (caso “In re DocuData Solutions, L.C.”) y tiene cargas financieras significativas. La operación se clasifica como una transacción entre partes relacionadas ya que comprador y vendedor comparten propiedad común.

La transacción incluye condiciones posteriores: si el plan de reorganización de bancarrota no es efectivo o no se cumplen otras condiciones antes del 7 de agosto de 2025, XBP puede rescindir la compra. La presentación no proporciona estados financieros proforma, sinergias ni guía de ganancias.

Implicaciones clave: XBP obtiene potencial beneficio de un activo en dificultades con un costo de efectivo mínimo, pero asume riesgo de reestructuración y enfrenta escrutinio de gobernanza debido a la naturaleza afiliada del acuerdo.

2025년 7월 15일, XBP Americas, LLC는 XBP Europe Holdings, Inc. (나스닥: XBP / XBPEW)의 전액 출자 자회사로서, 2025년 7월 3일 서명된 회원 지분 매매 계약에 따라 Exela Technologies, Inc.로부터 Exela Technologies BPA, LLC 및 그 자회사들(“BPA 그룹”)의 100% 지분 인수를 완료했습니다.

매매 가격은 단 $1.00에 불과했는데, 이는 BPA 그룹이 챕터 11 파산 절차(“In re DocuData Solutions, L.C.” 사건) 하에 운영 중이며 상당한 담보권이 설정되어 있기 때문입니다. 이 거래는 매수자와 매도자가 공동 소유권을 공유하는 특수 관계자 거래로 분류됩니다.

거래에는 후속 조건이 포함되어 있습니다: 파산 재조정 계획이 효력을 발휘하지 않거나 2025년 8월 7일까지 기타 조건이 충족되지 않을 경우, XBP는 매매를 철회할 수 있습니다. 제출 자료에는 예상 재무제표, 시너지 효과 또는 수익 가이던스가 포함되어 있지 않습니다.

주요 시사점: XBP는 최소 현금 비용으로 부실 자산에서 잠재적 이익을 얻는 반면, 구조조정 위험을 부담하고 거래의 계열사 성격으로 인해 거버넌스 감시를 받게 됩니다.

Le 15 juillet 2025, XBP Americas, LLC, une filiale en propriété exclusive de XBP Europe Holdings, Inc. (Nasdaq : XBP / XBPEW), a finalisé l'acquisition de 100 % d’Exela Technologies BPA, LLC et de ses filiales (le « Groupe BPA ») auprès d’Exela Technologies, Inc., conformément à l’accord d’achat de parts signé le 3 juillet 2025.

Le prix d’achat s’est élevé à seulement 1,00 $ car le Groupe BPA est en procédure de faillite sous le Chapitre 11 (dossier « In re DocuData Solutions, L.C. ») et supporte d’importantes charges financières. L’opération est qualifiée de transaction entre parties liées puisque l’acheteur et le vendeur ont une propriété commune.

La transaction comporte des conditions suspensives : si le plan de réorganisation de la faillite n’est pas effectif ou si d’autres conditions ne sont pas remplies avant le 7 août 2025, XBP peut annuler l’achat. Le dossier ne fournit pas d’états financiers pro forma, de synergies ou de prévisions de bénéfices.

Principales implications : XBP bénéficie d’un potentiel de valorisation d’un actif en difficulté à un coût en liquidités minimal, mais assume le risque de restructuration et fait face à un contrôle de gouvernance en raison de la nature affiliée de la transaction.

Am 15. Juli 2025 hat XBP Americas, LLC, eine hundertprozentige Tochtergesellschaft von XBP Europe Holdings, Inc. (Nasdaq: XBP / XBPEW), die Übernahme von 100 % von Exela Technologies BPA, LLC und deren Tochtergesellschaften (die „BPA-Gruppe“) von Exela Technologies, Inc. unter dem am 3. Juli 2025 unterzeichneten Mitgliedschaftsanteilkaufvertrag abgeschlossen.

Der Kaufpreis betrug lediglich 1,00 $, da die BPA-Gruppe sich im Chapter-11-Insolvenzverfahren befindet (Fall „In re DocuData Solutions, L.C.“) und erhebliche Belastungen aufweist. Der Deal wird als Geschäft mit verbundenen Parteien eingestuft, da Käufer und Verkäufer gemeinsame Eigentümer sind.

Die Transaktion enthält aufschiebende Bedingungen: Sollte der Insolvenzplan nicht wirksam werden oder andere Bedingungen bis zum 7. August 2025 nicht erfüllt sein, kann XBP den Kauf rückgängig machen. Es werden keine pro-forma-Finanzzahlen, Synergien oder Gewinnprognosen vorgelegt.

Wesentliche Auswirkungen: XBP erhält potenziellen Mehrwert aus einem notleidenden Vermögenswert zu minimalen Barzahlungskosten, übernimmt aber Restrukturierungsrisiken und steht aufgrund der verbundenen Natur des Geschäfts unter Governance-Prüfung.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
LA ROSA JOSEPH

(Last) (First) (Middle)
1420 CELEBRATION BLVD.
2ND FLOOR

(Street)
CELEBRATION FL 34747

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
La Rosa Holdings Corp. [ LRHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CEO, interim CFO
3. Date of Earliest Transaction (Month/Day/Year)
07/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/17/2025 P 75,000 A $7.64 180,272(5) D(1)(2)
Common Stock 07/07/2025 P 75,000 A $7.64 180,272(5) I(1)(2) By Spouse
Common Stock 47,500(5) I By Trust(3)
Common Stock 4(5) I By LLC(4)
Common Stock 750(5) I By children
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant to Purchase Common Stock $0.135(6) 07/17/2025 S 1,851,852(6) 12/02/2022 12/02/2027 Common Stock 1,851,852(6) $7.64 0 D(1)(2)
Warrant to Purchase Common Stock $0.135(6) 07/17/2025 S 1,851,852(6) 12/02/2022 12/02/2027 Common Stock 1,851,852(6) $7.64 0 I(1)(2) By Spouse
1. Name and Address of Reporting Person*
LA ROSA JOSEPH

(Last) (First) (Middle)
1420 CELEBRATION BLVD.
2ND FLOOR

(Street)
CELEBRATION FL 34747

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CEO, interim CFO
1. Name and Address of Reporting Person*
LA ROSA DEANA

(Last) (First) (Middle)
1420 CELEBRATION BLVD.
2ND FLOOR

(Street)
CELEBRATION FL 34747

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
Explanation of Responses:
1. This form is filed jointly by each of the reporting persons listed above. Joseph La Rosa and Deana La Rosa, Issuer's Chief Operating Officer, are husband and wife. Mr. La Rosa owns the shares of common stock directly and Ms. La Rosa owns them indirectly as Mr. La Rosa's spouse.
2. Represents a single issuance of shares of common stock of the Issuer to Mr. La Rosa, pursuant to Exchange Agreement between the Issuer and Mr. La Rosa signed on July 17, 2025.
3. Owned by JLR-JCCLT1 Land Trust, controlled by Mr. Joseph La Rosa. Mr. Joseph La Rosa is the trustee of the trust.
4. Owned by Celebration Office Condos, LLC, a company owned and controlled by Joseph La Rosa.
5. As adjusted for 1-for-80 reverse stock split effected by the Issuer on July 7, 2025.
6. This warrant was previously reported covering 50,000 shares of common stock at an exercise price of $5 per share, but was adjusted as follows pursuant to anti-dilution provisions of the warrant: 1)on 02/20/24 the number of shares underlying the warrant was adjusted to 166,667 shares and the exercise price was adjusted to $1.5; 2)on 08/16/24 the number of shares was adjusted to 423,729 shares and the exercise price was adjusted to $0.59; 3)on 11/01/24 the number of shares was adjusted to 667,913 shares and the exercise price was adjusted to $0.3743; 4)on 02/20/25 the number of shares was adjusted to 1,048,218 shares and the exercise price was adjusted to $0.2385; 4)on 03/10/2025 the number of shares was adjusted to 1,331,913 shares and the exercise price was adjusted to $0.1877; 6)on 04/21/25 the number of shares was adjusted to 1,851,852 shares and the exercise price was adjusted to $0.135.
/s/ Joseph La Rosa 07/21/2025
/s/ Deana La Rosa 07/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
La Rosa Holdings Corp

NASDAQ:LRHC

LRHC Rankings

LRHC Latest News

LRHC Latest SEC Filings

LRHC Stock Data

5.39M
607.56k
29%
0.58%
1.04%
Real Estate Services
Real Estate Agents & Managers (for Others)
Link
United States
CELEBRATION